CANCARINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 9.684
EU - Europa 5.762
AS - Asia 1.885
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 13
AF - Africa 11
SA - Sud America 8
Totale 17.377
Nazione #
US - Stati Uniti d'America 9.658
PL - Polonia 1.532
UA - Ucraina 1.444
CN - Cina 1.358
IT - Italia 1.099
DE - Germania 574
HK - Hong Kong 330
FI - Finlandia 300
GB - Regno Unito 237
IE - Irlanda 212
FR - Francia 208
IN - India 79
BE - Belgio 47
VN - Vietnam 45
RU - Federazione Russa 37
SE - Svezia 34
CA - Canada 23
IR - Iran 19
SG - Singapore 18
TR - Turchia 15
AU - Australia 13
EU - Europa 13
NL - Olanda 7
BD - Bangladesh 6
BR - Brasile 6
ES - Italia 6
RO - Romania 5
JP - Giappone 4
BG - Bulgaria 3
EG - Egitto 3
ZA - Sudafrica 3
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
HR - Croazia 2
ID - Indonesia 2
LV - Lettonia 2
MA - Marocco 2
MU - Mauritius 2
MX - Messico 2
PE - Perù 2
RS - Serbia 2
A1 - Anonimo 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 17.377
Città #
Warsaw 1.531
Fairfield 1.359
Woodbridge 1.150
Jacksonville 1.048
Houston 777
Ashburn 698
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 502
Wilmington 463
Princeton 418
Nanjing 366
Hong Kong 328
Dublin 210
New York 187
Beijing 172
Nanchang 136
Helsinki 125
Dearborn 113
Des Moines 103
Milan 103
Brescia 88
Hebei 82
Shenyang 77
Jiaxing 76
San Diego 73
Changsha 68
Tianjin 65
Rome 54
Jinan 52
Brussels 45
Dong Ket 44
Kunming 38
Verona 37
Boardman 33
Shanghai 32
Hangzhou 28
Lanzhou 27
Ningbo 24
San Mateo 23
Lancaster 20
Falls Church 19
Augusta 18
London 18
Monmouth Junction 18
Toronto 17
Zhengzhou 17
Leawood 16
Ardabil 15
Norwalk 14
San Francisco 14
Taizhou 14
Haikou 13
Bologna 12
Changchun 12
Kocaeli 12
Florence 11
Palermo 11
Turin 11
Bergamo 10
Naples 10
Orange 10
Atlanta 8
Dallas 8
Guangzhou 8
Napoli 8
Avellino 7
Catania 7
Edinburgh 7
Hefei 7
Kilburn 7
Bari 6
Melbourne 6
Mumbai 6
Phoenix 6
Prato 6
Redwood City 6
Taiyuan 6
Canberra 5
Chiswick 5
Foggia 5
Genova 5
Los Angeles 5
New Rochelle 5
Perugia 5
Pune 5
Berlin 4
Ferentino 4
Fuzhou 4
Grafing 4
Lachine 4
Nürnberg 4
Pesaro 4
Piemonte 4
Pisa 4
Siena 4
Trieste 4
Udine 4
Walnut 4
Totale 13.070
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 749
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 321
Incremental peritoneal dialysis: a 10 year single-centre experience 260
Low-protein diets for chronic kidney disease patients: The Italian experience 222
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 215
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 185
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 179
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 171
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 170
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 168
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 167
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 165
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 154
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 154
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 150
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 146
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 146
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 138
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 135
Nutritional treatment of advanced CKD: twenty consensus statements 135
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 118
Differing dialysis treatment strategies and outcome. 118
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 117
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 117
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 114
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 113
Assessment of calcemic status in dialyzed uraemic patients. 109
Vascular access in older patients: an Italian survey. 109
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 108
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 108
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 108
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 108
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 107
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 107
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 107
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 106
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 103
Dialysis initiation: what's the rush? 103
Diethylene Glycol Poisoning From Transcutaneous Absorption 102
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 102
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 102
Clinical policies on the management of chronic kidney disease patients in Italy. 101
Which vascular access for chronic hemodialysis in uremic elderly patients? 101
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 101
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 101
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 99
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 99
A more tubulocentric view of diabetic kidney disease 99
Porphyria and pseudo-porphyria in hemodialyzed patients. 98
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 98
Experience with cyclosporine. 98
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 98
A six year comparison of patient and technique survivals in CAPD and HD 97
The MEST score provides earlier risk prediction in lgA nephropathy 96
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 95
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 95
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 95
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 95
Porphyria cutanea tarda in a haemodialysed patient. 94
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 94
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 93
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 93
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 92
Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. 91
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 90
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 90
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 89
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 89
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 89
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 89
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics 88
Myocardial ultrasound tissue characterization in patients with chronic renal failure 88
Kidney transplantation in hiv-positive patients treated with a steroid-free immunosuppressive regimen. 88
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 87
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 87
Kidney transplantation in HIV-positive patients: a report of 14 cases 87
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 87
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 86
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 86
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 86
Transplantation outcome in patients PD and HD 85
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 85
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 85
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region 85
Strategy for preventing peritoneal dialysis failure. 84
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 84
The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients 84
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 84
Pulmonary calciphylaxis and metastatic calcification with acute respiratory failure in multiple myeloma. 84
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 83
Renal anemia: comparing current Eastern and Western European management practice (ORAMA). 83
PD or not PD? That is the question. 82
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 82
Outcome of peritoneal dialysis: comparative studies. 81
Fistula maturation: doesn't time matter at all? 81
Plasma exchange in the treatment of acute renal failure of myeloma. 81
De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012 81
Chronic Ambulatory Peritoneal Dialysis 80
Renal transplantation and peritoneal dialysis 80
Management of hypertension in chronic renal failure. 80
Totale 11.699
Categoria #
all - tutte 67.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.226 0 0 0 0 0 0 0 0 0 295 483 448
2019/20205.204 798 215 208 585 323 590 460 572 360 580 187 326
2020/20213.348 92 378 159 408 149 380 141 377 485 262 358 159
2021/20221.692 114 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.133 92 35 68 109 61 226 69 85 358 30 0 0
Totale 17.659